MENU
GNLX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Genelux (GNLX) Ownership - Who owns Genelux?

Genelux Corp is a clinical-stage biopharmaceutical company... Show more

Profile

Industry
N/A
Address
2625 Townsgate Road
Phone
+1 805 267-9889
Employees
23
Web
https://www.genelux.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
116.72M
P/E Ratio
N/A
Total Cash
19.92M
Projected Growth
N/A
Total Debt
1.62M
Revenue
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash/Share
0.45
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price

Fundamentals

GNLX
Capitalization
117M
P/E Ratio
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash
19.9M
Total Cash/Share
0.45
Total Debt
1.62M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
18.6M
P/B Ratio
6.28
Cash Flow
N/A
Earnings
-0.88
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
38K
Current Ratio
4.20
Current Revenue Per Employee
347.83
Dividends Per Share - Security
N/A
EBITDA
-31.07M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-97.69
Shares Held By Institutions
37.3M
Shares Outstanding - Current
44.7M
Total Liabilities
6.4M
Total Volume MTD
N/A
Value
-1
Gain YTD
-40.138
View a ticker or compare two or three
GNLX
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. GNLX showed earnings on November 05, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
2625 Townsgate Road
Phone
+1 805 267-9889
Employees
23
Web
https://www.genelux.com